NCT02923700View on ClinicalTrials.gov

Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

September 26, 2016

Primary Completion Date

September 26, 2017

Study Completion Date

May 27, 2021

Conditions
Osteoarthritis
Interventions
BIOLOGICAL

Leukocyte-rich PRP intra-articular injections

BIOLOGICAL

Leukocyte-poor PRP intra-articular injections

Trial Locations (1)

40136

Rizzoli Orthopaedic Institute, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER

NCT02923700 - Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter